Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

Israeli Biotechnology Company CollPlant, Producing Human Collagen For Tissue Repair, Raises $6 Million

The company also raised NIS 63 million in future options and hopes to bring two products to the European market by 2015.
Prof. Oded Shoseyov

 Prof. Oded Shoseyov

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

CollPlant Holdings Ltd. (TASE: CLPT) completed raising NIS 3.7 million (about $1 million) yesterday at a price of 23% above the minimum set due to surplus demand from institutions and the public at NIS 0.37 (about 0.10 Cent) per share with an issue that was 4.5 times oversubscribed.

Collplant is an Israeli biotechnology company producing human collagen, a protein vital for tissue repair, from genetically modified tobacco plants grown in greenhouses.

The technology behind CollPlant’s collagen was invented by the company’s co-founder Professor Oded Shoseyov, who transfered all five genes responsible for the production of the protein into a transgenic plant. Tobacco was perfect for this job because its genome is well known, it starts a new growing cycle every six weeks and it is not part of the food chain, so the genes cannot escape into the environment.

CollPlant is marketing its collagen as raw material to laboratories. The company is also developing products on its own, including a gel to accelerate healing diabetic ulcers, which the U.S. Food engaged in the development and production of medical devices for regenerative medicine for tissue repair based on human collagen.

Overall the company raised about $6 million this month in shares and also raised a further $18 million for the future in options.





You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.